Details of the Drug

General Information of Drug (ID: DMZX0VF)

Drug Name
Tavokinogene telseplasmid
Synonyms TAVO
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 2 [1]
Triple negative breast cancer 2C60-2C65 Phase 2 [1]
Drug Type
Gene therapy
Cross-matching ID
TTD ID
DT7O8R
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukine 12 (IL-12) TTG68FB IL12A_HUMAN ; IL12B_HUMAN Replacement [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients. Ann Oncol. 2020 Apr;31(4):532-540.